// App-Quantinova.ai

P197 : Evaluating the safety and factors associated with treatment cessation in Takayasu arteritis

Researchers

Presenter

  • Robert T Maughan

Principal Investigators

  • Andrew Porter

  • Chanaka Dahanayake

  • Claudia Ianonne

  • Ritu Alapat

  • Charis Pericleous

  • Taryn A Youngstein

  • Justin Mason

Medical Centers

  • Medical Oncology, Royal College of Surgeons in Ireland, Dublin, Ireland

  • National Heart and Lung Institute, Imperial College London, London, United Kingdom

  • Haematology Outpatient, IMPERIAL COLLEGE HEALTHCARE NHS TRUST, LONDON, United Kingdom

Locations

  • Ireland

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Takayasu arteritis

Biomarkers

  • N/A

Drug/Treatment

  • Glucocorticoid

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved